By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272


SEARCH JOBS


Industry
Healthcare

Segment
Pharmaceuticals





Company News
Astellas Pharma Inc. (ALPMY) Details Pipeline Progress At R&D Meeting 7/11/2014 8:10:48 AM
Astellas Pharma Inc. (ALPMY) Details Pipeline Progress At R&D Meeting 7/11/2014 6:48:00 AM
Basilea Pharmaceutica (BSLN.SW)'s Partner Astellas Pharma Inc. (ALPMY) Submits Isavuconazole U.S. NDA For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis 7/9/2014 2:01:03 PM
Astellas Pharma Inc. (ALPMY) Submits U.S. New Drug Application For Isavuconazole For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis 7/9/2014 10:26:22 AM
Astellas Pharma Inc. (ALPMY) Returns To "Give Kids The World" And Expands Partnership With Starlight Children's Foundation To Brighten The Lives Of Young Patients & Their Families 6/11/2014 10:01:54 AM
Astellas Pharma Inc. (ALPMY) Release: The New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Na├»ve Metastatic Prostate Cancer 6/2/2014 10:14:25 AM
Astellas Pharma Inc. (ALPMY) And Medivation, Inc. (MDVN) Receive Priority Review From FDA For XTANDI® (Enzalutamide) Capsules In Chemotherapy-Naive Advanced Prostate Cancer 5/6/2014 9:34:58 AM
Astellas Pharma Inc. (ALPMY) Makes $7.3 Million Deal With U.S. Department Of Justice 4/17/2014 6:34:32 AM
Astellas Pharma Inc. (ALPMY) Announces Marketing Approval In Japan For XTANDI® (Enzalutamide) Capsules, An Advanced Prostate Cancer Treatment 3/25/2014 6:47:44 AM
Astellas Pharma Inc. (ALPMY) And Daiichi Sankyo, Inc. (4568.t) Form Compound Library Sharing Partnership 3/20/2014 10:13:49 AM
12345678910...
//-->